4.5 Article

Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells

Related references

Note: Only part of the references are listed.
Article Surgery

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients

Giuseppe S. Netti et al.

Summary: mTOR inhibitors (mTOR-I) treatment is associated with a better immune response to COVID-19 vaccine in kidney transplant recipients (KTR), not only by increasing vaccine-induced antibodies but also by stimulating anti-SARS-CoV-2 T cell response.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Review Immunology

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

Soheila Fattahi et al.

Summary: COVID-19 is a severe respiratory infection caused by SARS-CoV-2 and is a major global challenge. Although several effective COVID-19 vaccines have been developed, our understanding of specific therapeutic drugs for COVID-19 treatment is still limited. The mTOR pathway plays an important role in viral replication, and mTOR pathway inhibitors may be a potential approach to anti-SARS-CoV-2 therapy.

IMMUNOLOGIC RESEARCH (2022)

Article Medicine, Research & Experimental

Possible effects of sirolimus treatment on the long-term efficacy of COVID-19 vaccination in patients with β-thalassemia: A theoretical perspective Hypothesis and Theory

Matteo Zurlo et al.

Summary: The COVID-19 pandemic has been a challenge for global health, emphasizing the need for effective vaccines. Recent studies have shown that patients with beta-thalassemia have a high mortality rate from COVID-19, likely due to their immune deficiencies. Immunosuppression may also impact the effectiveness of COVID-19 vaccines, suggesting the use of immunomodulatory molecules as a potential solution.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2022)

Letter Hematology

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

Rita Carsetti et al.

Summary: Patients with beta-thalassemia have a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection, making them a high-risk population. Vaccination is crucial in reducing mortality and morbidity for these frail patients. Limited data is available on the response of beta-thalassemia patients immunized with anti-SARS-CoV-2 mRNA vaccines.

BLOOD (2022)

Article Hematology

Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)

Cristina Zuccato et al.

Summary: The study demonstrates that low-dose sirolimus treatment in patients with beta-thalassemia can increase the expression of gamma-globin genes and reduce biochemical markers associated with ineffective erythropoiesis. This finding provides important insights for the development of new therapeutic approaches.

THERAPEUTIC ADVANCES IN HEMATOLOGY (2022)

Review Biochemistry & Molecular Biology

β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study

Mandana Zafari et al.

Summary: This study investigated the mortality and morbidity of infected beta-thal patients with COVID-19, showing that infected patients with beta-thal are at increased risk of mortality and morbidity.

HEMOGLOBIN (2021)

Review Immunology

Interleukin-1 as Innate Mediator of T Cell Immunity

Bram Van den Eeckhout et al.

Summary: The three-signal paradigm aims to capture how the innate immune system instructs adaptive immune responses through three defined actions, with a focus on the activities of IL-1 in shaping the adaptive immune response in DCs and T cells.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, General & Internal

Vaccines for older adults

Anthony L. Cunningham et al.

Summary: The global population aged 65 and older is increasing rapidly, with infections in this age group causing substantial morbidity and mortality. Improvements in vaccines for older people, including the addition of novel adjuvants and increasing antigen concentration, have been made to combat vaccine preventable diseases of aging.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Hematology

Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias

Francesca Vinchi et al.

Summary: The study suggests that free haem and iron may contribute to vascular dysfunction and sterile inflammation in hemolytic diseases, indicating the potential therapeutic benefit of iron/haem scavenging therapies in these conditions. The results show increased systemic haem and iron levels, associated with scavenger depletion and toxic 'free' species formation, as well as significantly elevated endothelial dysfunction, oxidative stress, and inflammation markers in hemolytic patients. Different markers were associated with haem- and iron-related parameters, with hereditary spherocytosis showing the highest levels of IL-6 and TNF alpha.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Article Geriatrics & Gerontology

Rapamycin Activates Mitophagy and Alleviates Cognitive and Synaptic Plasticity Deficits in a Mouse Model of Alzheimer's Disease

Hui Wang et al.

Summary: The study showed that rapamycin can improve cognitive and synaptic plasticity deficits induced by Alzheimer's disease through enhancing mitophagy, leading to restored learning and memory capabilities and positive effects on mitochondrial function.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2021)

Article Plant Sciences

Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein

Jessica Gasparello et al.

Summary: Sulforaphane may modulate the inflammatory response by inhibiting key molecules IL-6 and IL-8 involved in the COVID-19 cytokine storm, potentially controlling the hyperinflammatory state associated with SARS-CoV-2 infection.

PHYTOMEDICINE (2021)

Review Cardiac & Cardiovascular Systems

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity

Francesco Blasi et al.

Summary: Despite efforts of non-pharmacological interventions and tracing-testing strategy, SARS-CoV-2 continues to spread globally. Development of vaccines with different mechanisms of action is progressing, but challenges such as real-life effectiveness and emerging variants remain.

RESPIRATORY MEDICINE (2021)

Article Immunology

Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects

Eleonora Gallerani et al.

Summary: Research indicates that older individuals have defective primary SARS-CoV-2-specific CD8(+) T-cell responses, with lower magnitude and quality compared to younger adults, as well as recognizing a lower number of epitopes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Susceptibility of β-Thalassemia Heterozygotes to COVID-19

Sotirios Sotiriou et al.

Summary: This study found that beta-thalassemia has an impact on mortality from COVID-19, and factors such as male sex, increased age, hypertension, and other characteristics are associated with the severity, ICU admission rate, and mortality from COVID-19.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Review Biochemistry & Molecular Biology

Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies

Selami Demirci et al.

HUMAN MOLECULAR GENETICS (2020)

Article Hematology

Hereditary persistence of fetal hemoglobin

Dharmesh Chandra Sharma et al.

ASIAN JOURNAL OF TRANSFUSION SCIENCE (2020)

Review Tropical Medicine

A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients

Saber Soltani et al.

TROPICAL MEDICINE AND HEALTH (2020)

Article Respiratory System

The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis

Qi Wang et al.

RESPIRATORY RESEARCH (2020)

Article Cell Biology

The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia

Christophe Lechauve et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Review Cell Biology

Autophagy in T Cell Function and Aging

Fernando Macian

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Article Cell Biology

TORC1 inhibition enhances immune function and reduces infections in the elderly

Joan B. Mannick et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Multidisciplinary Sciences

T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells

Aakanksha Jain et al.

NATURE COMMUNICATIONS (2018)

Review Oncology

Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives

Marco Gallo et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)

Review Geriatrics & Gerontology

Inflammaging decreases adaptive and innate immune responses in mice and humans

Daniela Frasca et al.

BIOGERONTOLOGY (2016)

Article Biochemistry & Molecular Biology

Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming

Michael D. Buck et al.

Review Cardiac & Cardiovascular Systems

Untangling Autophagy Measurements All Fluxed Up

Roberta A. Gottlieb et al.

CIRCULATION RESEARCH (2015)

Article Oncology

Everolimus in diffuse large B-cell lymphomas

Michele Merli et al.

FUTURE ONCOLOGY (2015)

Review Gastroenterology & Hepatology

Everolimus in de novo liver transplant recipients: a systematic review

Cheng-Yong Tang et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)

Article Biology

The role of mitochondria in mTOR-regulated longevity

Yuehua Wei et al.

BIOLOGICAL REVIEWS (2015)

Review Cell Biology

Autophagy in T-cell development, activation and differentiation

Alisha W. Bronietzki et al.

IMMUNOLOGY AND CELL BIOLOGY (2015)

Article Immunology

Immunity to tetanus in major beta thalassemia patients

Abdolreza Sotoodeh Jahromi et al.

CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)

Article Oncology

Targeted Fetal Hemoglobin Induction for Treatment of Beta Hemoglobinopathies

Susan P. Perrine et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)

Article Cell Biology

High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART

L. A. Ramirez et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2014)

Article Cell Biology

mTOR inhibition improves immune function in the elderly

Joan B. Mannick et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Biology

Autophagy is a critical regulator of memory CD8+ T cell formation

Daniel J. Puleston et al.

ELIFE (2014)

Article Multidisciplinary Sciences

Immune Suppressant Unexpectedly Boosts Flu Vaccine

J. Cohen

SCIENCE (2013)

Article Medicine, Research & Experimental

The Molecular Basis of β-Thalassemia

Swee Lay Thein

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)

Proceedings Paper Biochemistry & Molecular Biology

IL-1β Strikingly Enhances Antigen-Driven CD4 and CD8 T-Cell Responses

S. Z. Ben-Sasson et al.

IMMUNITY AND TOLERANCE (2013)

Article Medicine, Research & Experimental

Pathophysiology and Clinical Manifestations of the β-Thalassemias

Arthur W. Nienhuis et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Review Pharmacology & Pharmacy

Everolimus: efficacy and safety in cardiac transplantation

S. Allan Schaffer et al.

EXPERT OPINION ON DRUG SAFETY (2010)

Review Immunology

The role of mTOR in memory CD8+T-cell differentiation

Koichi Araki et al.

IMMUNOLOGICAL REVIEWS (2010)

Article Hematology

Rapamycin-mediated induction of γ-globin mRNA accumulation in human erythroid cells

C Mischiati et al.

BRITISH JOURNAL OF HAEMATOLOGY (2004)

Article Oncology

Immunological status of thalassemia syndrome

U Ezer et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY (2002)

Review Pharmacology & Pharmacy

Sirolimus: A new agent for prevention of renal allograft rejection

EM Vazquez

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2000)